ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 41954652

Stage-dependent prognostic impact of GATA3/FOXA1-defined luminal-like subtype in upper tract urothelial carcinoma.

Ahn B and 2 others. Virchows Arch, 2026. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Stage-dependent prognostic impact of GATA3/FOXA1-defined luminal-like subtype in upper tract urothelial carcinoma. Papers, record 41954652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41954652

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Stage-dependent prognostic impact of GATA3/FOXA1-defined luminal-like subtype in upper tract urothelial carcinoma.
PubMed
Journal
Virchows Arch
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-04-09
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ahn BByungSoo
2Jung MMinsunhttps://orcid.org/0000-0002-8701-4282
3Moon KCKyung Chul

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
RS-2024-00341570Ministry of Science and ICT, South KoreaPubMed
RS-2025-02223506Ministry of Health and WelfarePubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128,867,446European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.Eur Urol2018https://conductscience.org/library/papers/28867446PubMed
231,563,503A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.Eur Urol2020https://conductscience.org/library/papers/31563503PubMed
333,863,885An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer.Nat Commun2021https://conductscience.org/library/papers/33863885PubMed
428,074,276In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival.Virchows Arch2017https://conductscience.org/library/papers/28074276PubMed
525,770,486A Molecular Pathologic Framework for Risk Stratification of Stage T1 Urothelial Carcinoma.Eur Urol2015https://conductscience.org/library/papers/25770486PubMed
634,129,823Molecular classification and diagnostics of upper urinary tract urothelial carcinoma.Cancer Cell2021https://conductscience.org/library/papers/34129823PubMed
728,601,352Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma.Eur Urol2017https://conductscience.org/library/papers/28601352PubMed
820,825,397Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005.BJU Int2011https://conductscience.org/library/papers/20825397PubMed
931,500,577Clinical outcomes of muscle invasive bladder Cancer according to the BASQ classification.BMC Cancer2019https://conductscience.org/library/papers/31500577PubMed
1033,086,575Non-Muscle-Invasive Bladder Carcinoma with Respect to Basal Versus Luminal Keratin Expression.Int J Mol Sci2020https://conductscience.org/library/papers/33086575PubMed

1 to 10 of 29

See all 29 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

None in this release.

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FOXA13,169PubTator's text mininghttps://conductscience.org/library/genes/3169NCBI Gene
GATA32,625PubTator's text mininghttps://conductscience.org/library/genes/2625NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41954652

GET https://conductscience.org/api/papers/v1/41954652/references?page=2

API referenceFor AI assistants